News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Articles|January 12, 2012

Home page open question: What's Your Take?

What is the single greatest challenge you face as a clinician?

We invite your comments. Click here for more details.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Trending on Psychiatric Times

Sex Differences, Sleep Problems, and Psychological Well-Being in Older Adults

Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack

Evidence-Based Nonpharmacological Interventions in Schizophrenia: Focus on Cognitive Impairment

Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression

GABA Deficits and Sleep Disruption in Early Alzheimer Disease